Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on...